Le Lézard
Classified in: Health
Subject: FEA

Medical technology companies to benefit from Picosun biocompatible materials


ESPOO, Finland, Nov. 23, 2021 /PRNewswire/ -- Picosun Group has launched a Medical Materials Library consisting of over ten materials intended for medical-related coating and encapsulation with Atomic Layer Deposition (ALD). ALD coatings are ultra-thin, and they guarantee hermetic encapsulation of virtually any implanted device.

The materials library is a reflection of over six years extensive research and development that shows ALD can render biocompatibility to a substrate coated with Picosun library materials. Biocompatibility tests were carried out according to ISO standards in accredited third-party laboratories. The performed tests included for example cytotoxicity, antimicrobial activity, skin irritation or sensitization, hemocompatibility, bacterial endotoxins, bioburden and sterilization residuals. From the tested materials Picosun is able to design tens of different types of end materials according to customer needs.

ALD technology provides dimensionless coating thus enabling miniaturization of components and devices in the field of electronic implants. Antibacterial function together with excellent barrier properties and outstanding corrosion resistance pave the way for using the materials both in electronic and orthopedic implants and show high potential in pharmaceutical packaging. The superior film uniformity and conformality ensure a pinhole-free coverage over even the smallest details of the device.

"The demonstrated results show the undisputable opportunities ALD offers to the medical sector already today. While the basic surgical principles and technologies have remained the same for decades, now ALD enables unforeseen applications potentially improving patient safety and cost-effectiveness by extending implant durability and reducing adverse effects", says Niku Oksala, professor of surgery at Tampere University and medical advisor for Picosun.

"Picosun's Medical Materials Library targeted to the medical device manufacturer segment reflects the innovative spirit of the company. I'm really excited over the fact that we are able to flexibly design tailored encapsulations according to our customers' needs. I'm especially proud of our medical customers and partners who are already in pre-clinical and clinical trials with their ALD coated devices", says Juhani Taskinen, Vice President, Medical Business Area of Picosun Group.

More information:

Juhani Taskinen
Vice President, Medical Business Area, Picosun Group
Tel: +358 50 4066 957
Email: [email protected]
www.picosun.com

Picosun provides the most advanced ALD® (Atomic Layer Deposition) thin film coating solutions for global industries. Picosun's ALD solutions enable technological leap into the future, with turn-key production processes and unmatched, pioneering expertise in the field ? dating back to the invention of the technology itself. Today, PICOSUN® ALD equipment are in daily manufacturing use in numerous leading industries around the world. Picosun is based in Finland, with subsidiaries in Germany, USA, Singapore, Japan, South Korea, China mainland and Taiwan, offices in India and France, and a world-wide sales and support network. Visit www.picosun.com.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/picosun-oy/r/medical-technology-companies-to-benefit-from-picosun-biocompatible-materials,c3458370

The following files are available for download:

https://mb.cision.com/Main/16058/3458370/1499851.pdf

Picosun_press_release_20211123

SOURCE Picosun Oy


These press releases may also interest you

at 13:23
(Family Features) Before the advent of antibiotics, infectious diseases, such as pneumonia, tuberculosis and diphtheria, were the most common causes of death in the industrialized world. Today, heart disease is the leading cause of death in the...

at 13:23
(Family Features) As a pet parent, you know your pet's needs are continually evolving. That's true during different stages of growth and even as the seasons change....

at 13:19
A substance use disorder (SUD) is a complex and often stigmatized health condition that affects countless individuals, families and communities. Stigma against people with a SUD extends beyond individual and interpersonal levels. The Shatterproof...

at 12:59
More than 400 members of the myasthenia gravis (MG) rare disease community will come together this week at the MGFA National Patient Conference for support and a better understanding of how to manage their disease while learning about the latest...

at 12:36
Kedrion Biopharma Inc., an international biopharmaceutical company specializing in the research and development, production, and commercialization of plasma-derived therapeutic products used in treating rare and serious diseases, announced today that...

at 12:28
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of XOLREMDItm (mavorixafor), recently approved by the U.S....



News published on and distributed by: